Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01) - Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)

Japanese Cancer Clinical Research Organization(JACCRO)0 个研究点目标入组 70 人开始时间: 2009年12月24日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patient with stump cancer 2) Patient who has an active infection. 3) Patient who has a hydronephrosis. 4) Patient who has myocardial infarction, unstable angina and uncontrolled irregular heartbeat within six months before registration. 5) Patient who has a serious complication. 6) Patient who has a radiotherapy history in the pelvic region. 7) Patient who has an active double cancer. However, cancers in situ that are considered as recovered by local treatment or legions equivalent to intramucosal cancer are not included in the active double cancers. 8) Patient who underwent exploratory laparotomy for cervical cancer. 9) Patient who is complicated by mental disease or psychological symptom and considered difficult to participate in the test. 10) Patient who is pregnant or of child-bearing potential or breast-feeding. 11) Patient who is diagnosed as a pyometra and there is no improvement in pyometra and infection despite the implementation of appropriate measures. 12) Other cases where doctors in attendance consider patients inappropriate.

发起方

Japanese Cancer Clinical Research Organization(JACCRO)